[HTML][HTML] The pivotal role of pathology in the management of lung cancer
MR Davidson, AF Gazdar, BE Clarke - Journal of thoracic disease, 2013 - ncbi.nlm.nih.gov
The last decade has seen significant advances in our understanding of lung cancer biology
and management. Identification of key driver events in lung carcinogenesis has contributed …
and management. Identification of key driver events in lung carcinogenesis has contributed …
Lung cancer biomarkers: present status and future developments
PT Cagle, TC Allen, RJ Olsen - Archives of Pathology …, 2013 - meridian.allenpress.com
The publication of the “Molecular Testing Guideline for Selection of Lung Cancer Patients for
EGFR and ALK Tyrosine Kinase Inhibitors: Guideline From the College of American …
EGFR and ALK Tyrosine Kinase Inhibitors: Guideline From the College of American …
[HTML][HTML] Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
KM Kerr, L Bubendorf, MJ Edelman, A Marchetti… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The Second …
consensus conferences to focus on specific issues in each type of tumour. The Second …
An expression signature as an aid to the histologic classification of non–small cell lung cancer
L Girard, J Rodriguez-Canales, C Behrens… - Clinical Cancer …, 2016 - AACR
Purpose: Most non–small cell lung cancers (NSCLC) are now diagnosed from small
specimens, and classification using standard pathology methods can be difficult. This is of …
specimens, and classification using standard pathology methods can be difficult. This is of …
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of …
BM Turner, PT Cagle, IM Sainz… - … of pathology & …, 2012 - meridian.allenpress.com
Context.—Differentiation of non–small cell carcinoma into histologic types is important
because of new, successful therapies that target lung adenocarcinoma (ACA). TTF-1 is a …
because of new, successful therapies that target lung adenocarcinoma (ACA). TTF-1 is a …
[HTML][HTML] A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis
X Zhou, W Wen, X Shan, W Zhu, J Xu, R Guo… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Differently expressed microRNAs (miRNAs) in the plasma of lung adenocarcinoma (LA)
patients might serve as biomarkers for LA detection. MiRNA expression profiling was …
patients might serve as biomarkers for LA detection. MiRNA expression profiling was …
[HTML][HTML] Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine …
R Kanagal-Shamanna, BP Portier, RR Singh… - Modern pathology, 2014 - Elsevier
Increasing use of fine needle aspiration for oncological diagnosis, while minimally invasive,
poses a challenge for molecular testing by traditional sequencing platforms due to high …
poses a challenge for molecular testing by traditional sequencing platforms due to high …
Combining deep learning and coherent anti-Stokes Raman scattering imaging for automated differential diagnosis of lung cancer
Lung cancer is the most prevalent type of cancer and the leading cause of cancer-related
deaths worldwide. Coherent anti-Stokes Raman scattering (CARS) is capable of providing …
deaths worldwide. Coherent anti-Stokes Raman scattering (CARS) is capable of providing …
FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT
J Feng, X Zhang, H Zhu, X Wang, S Ni, J Huang - PloS one, 2012 - journals.plos.org
Background We determined the expression of forkhead box Q1 (FoxQ1), E-cadherin (E-cad),
Mucin 1 (MUC1), vimentin (VIM) and S100 calcium binding protein A4 (S100A4), all …
Mucin 1 (MUC1), vimentin (VIM) and S100 calcium binding protein A4 (S100A4), all …
Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents
PT Cagle, QJ Zhai, L Murphy… - Archives of pathology & …, 2013 - meridian.allenpress.com
Context.—Lung cancer is the number one cause of cancer deaths in the United States and
globally. The advent of targeted therapies has offered a new treatment paradigm for lung …
globally. The advent of targeted therapies has offered a new treatment paradigm for lung …